Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 157, Issue 5 PART I, 1998, Pages 1423-1428

  Van Suylen, Robert J ^a,b   Smits, Jos F M ^a   Daemen, Mat J A P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN;

ANIMAL EXPERIMENT; ARTERY MUSCLE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; HEART HEMODYNAMICS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPOXIA; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION; PULMONARY HYPERTENSION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADAPTATION, PHYSIOLOGICAL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANOXIA; ARTERIOLES; BLOOD PRESSURE; CAPTOPRIL; HYPERTENSION, PULMONARY; HYPERTROPHY, LEFT VENTRICULAR; MALE; MONOCROTALINE; PULMONARY ARTERY; RATS; RATS, WISTAR;

EID: 0031747165     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.157.5.9709050     Document Type: Article

References (21)

1. Klinger, J. R., and N. S. Hill. 1991. Right ventricular dysfunction in chronic obstructive pulmonary disease: evaluation and management. Chest 99:715-723.
2. Weitzenblum, E., R. Kessler, M. Oswald, and P. Fraisse. 1994. Medical treatment of pulmonary hypertension in chronic lung disease. Eur. Respir. J. 7:148-152.
3. D'Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, J. T. Kernis, P. S. Levy, G. G. Pietra, L. M. Reid, J. T. Reefes, S. Rieh, C. E. Vreim, G. W. Williams, and M. Wu. 1991. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med. 115:343-349.
4. Rabinovitch, M., S. G. Haworth, A. R. Castaneda, A. S. Nadas, and L. M. Reid. 1978. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58:1107-1122.
5. Bush, A., C. M. Busst, S. G. Haworth, A. A. Hislop, W. B. Knight, B. Corrin, and E. A. Shinebourne. 1988. Correlations of lung morphology, pulmonary vascular resistance, and outcome in children with congenital heart disease. Dr. Heart J. 59:480-485.
6. Frescura, C., G. Thiene, E. Franceschini, E. Talenti, and A. Mazzucco. 1987. Pulmonary vascular disease in infants with complete atrioventricular septal defect. Int. J. Cardiol. 15:91-103.
7. Haworth, S. G. 1987. Pulmonary vascular disease in ventricular septal defect: structural and functional correlations in lung biopsies from 85 patients, with outcome of intracardiac repair. J. Pathol. 152:157-168.
8. Haworth, S. G. 1986. Pulmonary vascular bed in children with complete atrioventricular septal defect: relation between structural and hemodynamic abnormalities. Am. J. Cardiol. 57:833-839.
9. Clozel, J. P., C. Saunier, D. Hartemann, and W. Fischli. 1991. Effects of cilazapril, a novel angiotensin converting enzyme inhibitor, on the structure of pulmonary arteries of rats exposed to chronic hypoxia. J. Cardiovasc. Pharmacol. 17:36-40.
10. Cassis, L. A., P. E. Rippetoe, E. E. Soltis, D. J. Painter, R. Fitz, and M. N. Gillespie. 1992. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. J. Pharmacol. Exp. Ther. 262:1168-1172.
11. Meyrick, B., W. Gamble, and L. Reid. 1980. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239:H692-H702.
12. Rabinovitch, M., M. Mullen, H. C. Rosenberg, K. Maruyama, H. O'Brodovich, and P. M. Olley. 1988. Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat. Am. J. Physiol. 254: H500-H508.
13. Mulvany, M. J., G. L. Baumbach, C. Aalkjaer, A. M. Heagerty, N. Korsgaard, E. L. Schriffrin, and D. D. Heistad. 1996. Vascular remodeling. Hypertension 28:505-506.
14. Heagerty, A. M., C. Aalkjaer, S. J. Bund, N. Korsgaard, and M. J. Mulvany. 1993. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 21:391-397.
15. Thybo, N. K., N. Stephens, A. Cooper, C. Aalkjaer, A. M. Heagerty, and M. J. Mulvany. 1995. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 25:474-481.
16. Deng, L. Y., and E. L. Schiffrin. 1992. Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am. J. Hypertens. 5:817-822.
17. Thybo, N. K., N. Korsgaard, S. Eriksen, K. L. Christensen, and M. J. Mulvany. 1994. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 23:659-666.
18. Norrelund, H., K. L. Christensen, N. J. Samani, P. Kimber, M. J. Mulvany, and N. Korsgaard. 1994. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24:301-308.
19. Korsgaard, N., and M. J. Mulvany. 1998. Cellular hypertrophy in mesenteric resistance vessels from renal hypertensive rats. Hypertension 12: 162-167.
20. Rabinovitch, M., W. Gamble, A. S. Nadas, O. S. Miettinen, and L. Reid. 1979. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236:H818-H827.
21. Hislop, A., and L. Reid. 1976. New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br. J. Exp. Pathol. 57:542-554.